CIK 0001335105 · Non-accelerated filer<br>Smaller reporting company
NOMAD POWER SOLUTIONS, INC.
Sign in to watch- Ticker
- NMAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 202903526
- Phone
- 310 203 2902
- Business address
- 433 PLAZA REAL, SUITE 275, BOCA RATON, FL, 33432
- Former names
- LIXTE BIOTECHNOLOGY HOLDINGS, INC., SRKP 7 INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 3 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-09 | Pursglove Geordan Garrett Resigned as CEO & Chairman | Grant or award | +1,500,000 | 2,122,687 | ||
| 2026-07-01 | Stazzone Peter Chief Financial Officer | Grant or award | +50,000 | 100,000 | ||
| 2026-07-01 | Sawyer Jason David Director | Grant or award | +40,000 | 65,000 | ||
| 2026-07-01 | Pursglove Geordan Garrett CEO and Chairman of the Board | Grant or award | +350,000 | 700,000 | ||
| 2026-07-01 | Primus Guy Warren Director | Grant or award | +15,000 | 40,000 | ||
| 2026-07-01 | Holloway Michael Andrew Director | Grant or award | +15,000 | 40,000 | ||
| 2026-07-01 | Felix Lourdes Director | Grant or award | +30,000 | 55,000 | ||
| 2026-05-29 | Porter Stuart D Director | Grant or award | +25,000 | 25,000 | ||
| 2026-04-15 | Stazzone Peter Chief Financial Officer | Grant or award | +50,000 | 50,000 | ||
| 2026-04-15 | Stazzone Peter Chief Financial Officer | Returned to the company · Options to Purchase Common Stock | −50,000 | 0 | ||
| 2026-04-15 | Sawyer Jason David Director | Grant or award | +25,000 | 25,000 | ||
| 2026-04-15 | Sawyer Jason David Director | Returned to the company · Options to Purchase Common Stock | −25,000 | 0 | ||
| 2026-04-15 | Pursglove Geordan Garrett CEO and Chairman of the Board | Grant or award | +350,000 | 350,000 | ||
| 2026-04-15 | Pursglove Geordan Garrett CEO and Chairman of the Board | Returned to the company · Options to Purchase Common Stock | −350,000 | 0 | ||
| 2026-04-15 | Primus Guy Warren Director | Grant or award | +25,000 | 25,000 | ||
| 2026-04-15 | Primus Guy Warren Director | Returned to the company · Stock Option (right to buy) | −25,000 | 0 | ||
| 2026-04-15 | Holloway Michael Andrew Director | Grant or award | +25,000 | 25,000 | ||
| 2026-04-15 | Holloway Michael Andrew Director | Returned to the company · Options to Purchase Common Stock | −25,000 | 0 | ||
| 2026-04-15 | Felix Lourdes Director | Grant or award | +25,000 | 25,000 | ||
| 2026-04-15 | Felix Lourdes Director | Returned to the company · Stock Option (right to buy) | −25,000 | 0 |
Page 1 of 8 · 145 trades